Literature DB >> 22914670

Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population.

Haixia Zhou1, Jing Yang, Dengxue Li, Jun Xiao, Bo Wang, Lan Wang, Chunlan Ma, Sicheng Xu, Xuemei Ou, Yulin Feng.   

Abstract

Genome-wide association studies and integrative genomics approaches have demonstrated significant associations between chronic obstructive pulmonary disease (COPD) and single-nucleotide polymorphisms (SNPs) in the chromosome 15q25 region that includes iron-responsive element binding protein 2 gene (IREB2) and CHRNA3/5 in non-Asian populations. We investigated whether IREB2 and CHRNA3/5 polymorphisms would be associated with COPD susceptibility and COPD-related phenotypes in a Chinese Han population. Eight SNPs (rs2568494, rs2656069, rs10851906, rs1964678, rs12593229, rs965604, rs13180, rs17483929) in IREB2 gene and four SNPs (rs16969968, rs1051730, rs938682, rs8034191) in or near CHRNA3/5 locus were genotyped in a case-control study (680 COPD patients and 687 controls). No significant associations were found between any of the SNPs and COPD in either former-smokers or current-smokers. Two SNPs (rs2656069 and rs10851906) in IREB2 were associated with COPD (P=0.045 and 0.032, respectively) in non-smoker. Four SNPs (rs1964678, rs12593229, rs965604 and rs13180) in IREB2 were associated with forced expiratory volume in 1 s (FEV(1))% predicted and three SNPs (rs16969968, rs8034191 and rs1051730) in CHRNA3/5 were both associated with FEV(1)% predicted and FEV(1)/FVC in COPD cases (P range 0.007-0.050). The SNP rs8034191 near CHRNA3/5 locus was significantly associated with pack-years of smoking in COPD patients (P=0.033). We demonstrated IREB2 polymorphisms were associated with COPD in non-smoking subjects, and the effect of IREB2 gene on COPD may be independent from smoking and independent from CHRNA3/5 gene cluster. Besides, we confirmed that SNPs in these two gene loci were associated with pulmonary function and CHRNA3/5 polymorphism was associated with pack-year of smoking in COPD patients in the Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914670     DOI: 10.1038/jhg.2012.104

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  16 in total

Review 1.  Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use.

Authors:  W E Melroy-Greif; J A Stitzel; M A Ehringer
Journal:  Genes Brain Behav       Date:  2015-12-23       Impact factor: 3.449

Review 2.  Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung.

Authors:  Toru Nyunoya; Yohannes Mebratu; Amelia Contreras; Monica Delgado; Hitendra S Chand; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

3.  Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics.

Authors:  Ivana Nedeljkovic; Elena Carnero-Montoro; Lies Lahousse; Diana A van der Plaat; Kim de Jong; Judith M Vonk; Cleo C van Diemen; Alen Faiz; Maarten van den Berge; Ma'en Obeidat; Yohan Bossé; David C Nickle; Bios Consortium; Andre G Uitterlinden; Joyce J B van Meurs; Bruno C H Stricker; Guy G Brusselle; Dirkje S Postma; H Marike Boezen; Cornelia M van Duijn; Najaf Amin
Journal:  Eur J Hum Genet       Date:  2018-02-08       Impact factor: 4.246

Review 4.  Heterogeneity of chronic obstructive pulmonary disease: from phenotype to genotype.

Authors:  Xu Chen; Xiaomao Xu; Fei Xiao
Journal:  Front Med       Date:  2013-12       Impact factor: 4.592

5.  The "Iron"-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease.

Authors:  Suzanne M Cloonan; Sharon Mumby; Ian M Adcock; Augustine M K Choi; Kian Fan Chung; Gregory J Quinlan
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

6.  Gene susceptibility identification in a longitudinal study confirms new loci in the development of chronic obstructive pulmonary disease and influences lung function decline.

Authors:  Jungang Xie; Hongxu Wu; Yuzhu Xu; Xiaojie Wu; Xue Liu; Jin Shang; Jianping Zhao; Junling Zhao; Jianmiao Wang; Charles S Dela Cruz; Weining Xiong; Yongjian Xu
Journal:  Respir Res       Date:  2015-04-18

7.  Four SNPs in the CHRNA3/5 alpha-neuronal nicotinic acetylcholine receptor subunit locus are associated with COPD risk based on meta-analyses.

Authors:  Kai Cui; Xiaoyan Ge; Honglin Ma
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

8.  Molecular mechanisms underlying variations in lung function: a systems genetics analysis.

Authors:  Ma'en Obeidat; Ke Hao; Yohan Bossé; David C Nickle; Yunlong Nie; Dirkje S Postma; Michel Laviolette; Andrew J Sandford; Denise D Daley; James C Hogg; W Mark Elliott; Nick Fishbane; Wim Timens; Pirro G Hysi; Jaakko Kaprio; James F Wilson; Jennie Hui; Rajesh Rawal; Holger Schulz; Beate Stubbe; Caroline Hayward; Ozren Polasek; Marjo-Riitta Järvelin; Jing Hua Zhao; Deborah Jarvis; Mika Kähönen; Nora Franceschini; Kari E North; Daan W Loth; Guy G Brusselle; Albert Vernon Smith; Vilmundur Gudnason; Traci M Bartz; Jemma B Wilk; George T O'Connor; Patricia A Cassano; Wenbo Tang; Louise V Wain; María Soler Artigas; Sina A Gharib; David P Strachan; Don D Sin; Martin D Tobin; Stephanie J London; Ian P Hall; Peter D Paré
Journal:  Lancet Respir Med       Date:  2015-09-21       Impact factor: 30.700

9.  IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease.

Authors:  Jin Hwa Lee; Michael H Cho; Craig P Hersh; Merry-Lynn N McDonald; J Michael Wells; Mark T Dransfield; Russell P Bowler; David A Lynch; David A Lomas; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Cell Mol Biol       Date:  2015-03       Impact factor: 6.914

10.  Variants in the 15q24/25 locus associate with lung function decline in active smokers.

Authors:  Firdaus A A Mohamed Hoesein; Els Wauters; Wim Janssens; Harry J M Groen; Joanna Smolonska; Cisca Wijmenga; Dirkje S Postma; H Marike Boezen; Pim A De Jong; Marc Decramer; Jan-Willem J Lammers; Diether Lambrechts; Pieter Zanen
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.